China's AIM Vaccine up after co says operations, finances normal

AIM Vaccine

10/10/2023 05:09

** Shares of AIM Vaccine  6660.HK  jump as much as 24.1% to
HK$13.78, on track to rebound from a record low hit on Monday
    ** Stock on track for biggest one-day pct rise since March
13, and to snap three straight sessions of decline; biggest pct
gainer in Hang Seng Composite Index  .HSCI 
    ** Co says a one year lock-up period of its H Shares in
issue prior to its listing expired on Oct. 6 and became
available for trading on the Hong Kong bourse on Oct. 9
    ** Adds operations, financial conditions and sales of
vaccine products are normal, and research and development of
vaccines are progressing normally
    ** Hang Seng Commerce & Industry Index  .HSNC  rises 1.7%
and healthcare index  .HSCIH  gains 0.2%
    ** Hang Seng Composite Index  .HSCI  and Hang Seng Index
 .HSI  climb 1.1% and 1.3% respectively
    ** Stock down 44.8% YTD

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))